About My Health Careers Internship MedBlogs Contact us

Scientists Develop Nanoparticle Containing Drug That Fights Cancer Genes

by Rajashri on September 17, 2008 at 5:05 PM
Font : A-A+

 Scientists Develop Nanoparticle Containing Drug That Fights Cancer Genes

A safer and more effective way of targeting cancer-causing genes in cancer cells has been devised by scientists at Penn State College of Medicine.

They have administered nanoparticles filled with a drug that targets two genes that trigger melanoma cancer.


According to the scientists, the nanomedical approach could offer a potential cure for the cancer.

The new treatment is administered through an ultrasound device and targets cancer-causing genes in cancer cells without harming normal tissue.

"It is a very selective and targeted approach. And unlike most other cancer drugs that inadvertently affect a bunch of proteins, we are able to knock out single genes," said Gavin Robertson, associate professor of pharmacology, pathology and dermatology, Penn State College of Medicine.

They thought that "silencing RNA" (siRNA), strands of RNA molecules that knock out specific genes, could turn off the two cancer-causing genes and potentially treat the deadly disease more effectively.

"siRNA checks the expression of the two genes, which then lowers the abnormal levels of the cancer causing proteins in cells," explained Robertson, who is lead author of the study.

Recently, researchers have closed in on two key genes -- B-Raf and Akt3 -- that cause melanoma. B-Raf, the most frequently mutated gene in melanoma, produces the mutant protein, B-Raf, which helps mole cells survive and grow but does not form melanomas on its own.

They also found earlier that a protein called Akt3 regulates the activity of the mutated B-Raf, which aids the development of melanoma.

Robertson said that the drug used specifically targets Akt3 and the mutant B-Raf and therefore does not affect normal cells.

However, it's not easy to knock out specific genes, for delivering the siRNA drug to cancerous cells is rather difficult, as protective layers in the skin not only keep drugs out, but chemicals in the skin quickly degrade the siRNA.

In order to ward off these two problems, the researchers engineered hollow nano-sized particles -- nanoliposomes -- from globes of fatty acids into which they packed the siRNA.

Later, they used a portable ultrasound device to temporarily create microscopic holes in the surface of the skin, which would enable the drug-filled particles to leak into tumour cells beneath.

"Think of it as tiny basketballs that each protect the siRNA inside from getting degraded by the skin. These basketballs fall through the holes created by the ultrasound and are taken up by the tumor cells, thereby delivering the siRNA drug into the tumor cells," explained Robertson.

When they exposed lab-generated skin -- made from human connective tissue -- containing early cancerous lesions to the treatment 10 days after the skin was created, the siRNA reduced the ability of cells containing the mutant B-Raf to multiply by nearly 60 to 70 percent, and more than halved the size of lesions after three weeks.

"This is essentially human skin with human melanoma cells, which provides an accurate picture of how the drug is acting. If you knock down each of these two genes separately, you are able to reduce tumor development somewhat. But knocking them down together leads to synergistic reduction of tumor development," said Robertson.

The study appeared in the latest issue of the journal Cancer Research.

Source: ANI

News A-Z
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Cancer and Homeopathy Signature Drug Toxicity Cancer Facts Cancer Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Immune Checkpoint Inhibitors for Cancer Treatment Non-Communicable Diseases 

Recommended Reading
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of ....
Encyclopedia section of medindia explains in brief Introduction To Biopsy...
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Health Benefits of Dandelion Plant
What is dandelion? Dandelion greens are nutrition powerhouses with a wide range of health benefits. ...
Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has appro...
Non-Communicable Diseases
Non-Communicable Diseases (NCDs) are a group of chronic non-infectious diseases which include Cardio...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use